Glue (toluene) abuse: Increased QT dispersion and relation with unexplained syncope

Inhalation Toxicology

Volumn 20, Issue 1, 2008, Pages 37-41

  Alper, Ahmet Taha ^a,c   Akyol, Ahmet ^a   Hasdemir, Hakan ^a   Nurkalem, Zekeriya ^a   Güler, Özkan ^b   Güvenç, Tolga Sinan ^a   Erdinler, Izzet ^a   Çakmak, Nazmiye ^a   Eksik, Abdurrahman ^a   Gürkan, Kadir ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUE; TOLUENE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HUMAN; INHALANT ABUSE; MALE; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; SYMPTOMATOLOGY; SYNCOPE;

ADHESIVES; ADULT; HUMANS; LONG QT SYNDROME; MALE; SUBSTANCE-RELATED DISORDERS; SYNCOPE; TOLUENE;

SYNCOPE;

EID: 38849205006     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370701758304     Document Type: Article

References (35)

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th ed. rev. (DSM - IV), p. 239. Washington, DC: American Psychiatric Association.
2. Barr, C. S., Naas, A., Freeman, M., et al. 1994. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343:327-329.
3. Bass, M. 1970. Sudden sniffing death. J. Am. Med. Assoc. 212:2075-2079.
4. Bazett, H. C. 1920. An analysis of time-relations of eletrocardiograms. Heart 7:353-370.
5. Becker, A E., Grinspoon, S. K., and Klibanski, A. 1999. Eating disorders. N. Engl. J. Med. 340:1092-1098.
6. Bowen, S. E., Daniel, J., and Balster, R. L. 1999. Death associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend. 53:239-245.
7. Brignole, M., Alboni, P., Benditt, D. G., et al. 2004. ESC Guidelines on Management (Diagnosis and Treatment) of Syncope Update 2004. The Task Force on Syncope, European Society of Cardiology. Eur. Heart J. 25:2054-2072.
8. Buja, G., Miorelli, M., Turrini, P., et al. 1993. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am. J. Cardiol. 72:973-976.
9. Carder, J. R., and Fuerst, R. S. 1997. Myocardial infarction after toluene inhalation. Pediatr. Emerg. Care 13:117-119.
10. Cardoso, C., Salles, G., Bloch, K., Deccache, W., et al. 2001. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int. J. Cardiol. 79:253-262.
11. Choy, A. M., Lang, C. C., Roden, D. M., et al. 1998. Abnormalities of the QT interval in primary disorders of autonomic failure. Am. Heart J. 136:664-671.
12. Cruz, S. L., Orta-Salazar, G., Gauthereau, M. Y., et al. 2003. Inhibition of cardiac sodium currents by toluene exposure. Br. J. Pharmacol. 140:653-660.
13. Darbar, D., Luck, J., Davidson, N., et al. 1996. Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. Br. Med. J. 312:874-878.
14. Day, C. P., McComb, J. M., and Campbell, R. W. F. 1990. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br. Heart J. 63:342-344.
15. Fitzpatrick, A. P., Theodorakis, G., Vardas, P., et al. 1991. Methodology of head-up tilt testing in patients with unexplained syncope. J. Am. Coll. Cardiol. 17:125-130.
16. Flanagan, R. J., Ruprah, M., Meredith, T. J., et al. 1990. An introduction to the clinical toxicology of volatile substances. Drug Safety 5:359-383.
17. Fu, G. S., Meissner, A., and Simon, R. 1997. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur. Heart J. 18:281-289.
18. Glancy, J. M., Weston, P. J., Bhullar, H. K., et al. 1996. Reproducibility and automatic measurement of QT dispersion. Eur. Heart J. 17:1035-1039.
19. Henry, W. L., DeMaria, A., Gramiak, R., et al. 1980. Report of the American Society of Echocardiography Committe on Nomenclature and Standards in Two Dimensional Echocardiography. Circulation 62:212-217.
20. Lisowska, A., Skibinska, E., and Musial, W. J. 2004. Severe heart failure due to toxic cardiomyopathy in a young patient. A case report. Kardiol. Pol. 60:372-373.
21. Lof, A., Wigaeus Hjelm, E., Colmsjo, A., et al. 1993. Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to 2H8-toluene. Br. J. Ind. Med. 50:55-59.
22. Manttari, M., Oikarinen, L., Manninen, V., et al. 1997. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart 78:268-272.
23. Meadows, R., and Verghese, A. 1996. Medical complications of glue sniffing. South. Med. J. 89:455-462.
24. Murakawa, Y., Inoue, H, Nozaki, A., et al. 1992. Role of sympathovagal interaction in diurnal variation of QT intreval. Am. J. Cardiol. 69:339-343.
25. Murata, K., Aaraki, S., and Yokoyama, Y. 1993. Cardiac autonomic dysfunction in rotogravure printers exposed to toluene in relation to peripheral nerve conduction. Ind. Health 31:79-90.
26. Ögel, K., Tamar, D., and Çakmak, D. 1998. Alook to Turkey's situation regarding to substance abuse problem. Turk. J. Psychiatry 9:301-307.
27. Perkiomaki, J. S., Koistinen, M. J., Yli-Mayry, S., et al. 1995. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J. Am. Coll. Cardiol. 26:174-179.
28. Ramsey, J., Anderson, H. R., Bloor, K., et al. 1989. An introduction to the practice, prevalence and chemical toxicology of volatile substance abuse. Hum. Toxicol. 8:261-269.
29. Sharp, C. W., and Rosenberg, N. L. 1997. Inhalants. In Substance abuse. A comprehensive textbook, eds. J. H. Lowinson, P. Ruiz, R. B. Millman, and J. G. Langrod, pp. 246-264. Baltimore, MD: Williams & Wilkins.
30. Shepherd, R. T. 1989. Mechanism of sudden death associated with volatile substance abuse. Hum. Toxicol. 8:287-292.
31. Tran, H. J., Fan, C. H., Tu, W. Q., et al. 1998. QT measurement: A comparison of three simple methods. Ann. Noninvas. Electrocardiol. 3:228-231.
32. U.S. Department of Health and Human Services. 2001. Monitoring the future survey release. Smoking among teenagers decreases sharply and increase in ecstasy use slows. U.S. Department of Health and Human Services HHS News, December 19. Retrieved July 3, 2003, from www.nida. nih.gov/MedAdv/01/NR12-19. html.
33. Vural, M., and Ogel, K. 2006. Dilated cardiomyopathy associated with toluene abuse. Cardiology 105:158-161.
34. Vervaet, P., and Amery, W. 1993. Reproducibility of QTcmeasurements in healty volunteers. Acta Cardiol. 48(6):555-564.
35. Zareba, W., Moss, A. J., and le Cessie, S. 1994. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am. J. Cardiol. 74:550-553.